Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Completed · Phase 3

Conditions studied: Parkinson's Disease, Parkinson Disease, Dyskinesias

In brief

This study evaluates how effective a new formulation of a marketed drug is in increasing the time to onset of dyskinesia (abnormal twisting, writhing movements) in patients with Parkinson's Disease who have been taking levodopa for less than 2 years.

Key facts

Study ID

NCT00363727

Run by

GlaxoSmithKline

People needed

209

Starts

2003-12-01

Expected to finish

2006-01-01

Last updated by the study team

2017-01-18

Who can join

Age: 30 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be on 600mg or less of levodopa therapy for two years or less.
• Must be on a stable dose of levodopa therapy for at least 4 weeks prior to screening.

You may not qualify if…

• Current or past history of Dyskinesia.
• State of dementia or have a MMSE score < 26 at screening.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Sun City, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — La Jolla, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Newport Beach, California, United States
• GSK Investigational Site — Oxnard, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Boulder, Colorado, United States
• GSK Investigational Site — Danbury, Connecticut, United States
• GSK Investigational Site — Newark, Delaware, United States
• GSK Investigational Site — Boca Raton, Florida, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Gainesville, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Palm Beach Gardens, Florida, United States
• GSK Investigational Site — Pembroke Pines, Florida, United States
• GSK Investigational Site — Port Charlotte, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Augusta, Georgia, United States
• GSK Investigational Site — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.